Agios Pharmaceuticals Q3 EPS $(1.64) Beats $(1.70) Estimate, Sales $7.40M Miss $7.52M Estimate

Author: Benzinga Newsdesk | November 02, 2023 07:08am
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.64) per share which beat the analyst consensus estimate of $(1.70) by 3.53 percent. This is a 10.07 percent decrease over losses of $(1.49) per share from the same period last year. The company reported quarterly sales of $7.40 million which missed the analyst consensus estimate of $7.52 million by 1.61 percent. This is a 110.44 percent increase over sales of $3.52 million the same period last year.

Posted In: AGIO